miscsubjectsautonomous operating environment
Evidence review

PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-blood-pressure-meds`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-blood-pressure-meds

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-blood-pressure-meds/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-blood-pressure-meds/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-blood-pressure-meds/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-blood-pressure-meds/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Antihypertensives (various)

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why PT-141 might help you

  1. You are reading about Antihypertensives (various) — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

Why Antihypertensives (various) matters for you

  1. Drug: Antihypertensives (various)
  2. What it does: Symptom control; context-dependent tissue effects.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • PT-141 → sexual / CNS arousal

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 10
  • Claims tagged human evidence: 8
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 28
  • Reddit posts catalogued: 22
  • X posts catalogued: 5
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 38

Quantified confidence (this ledger): 0.95 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Palatin Announces Publication of Vyleesi fMRI Study (source s1)

Double-blind placebo-controlled crossover fMRI study in HSDD women showing central effects.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

VYLEESI (bremelanotide) FDA Label (source s2)

Official FDA approval and mechanism description.

Evidence type: Published research.

Long-Term Safety and Efficacy of Bremelanotide (source s3)

Pooled clinical study data on BP effects.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

An evaluation of bremelanotide injection for the treatment of HSDD (source s4)

Review confirming approved indications and lack of broader ED data.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Safety Profile of Bremelanotide Across the Clinical Development Program (source s5)

2022 review of bremelanotide safety from 43 studies; notes transient BP increases and caution for CV risk patients with well-controlled BP.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (source s6)

Phase 3 trial details for bremelanotide (PT-141) in HSDD, including safety monitoring.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Peptides for Sexual Dysfunction: What Clinicians Should Know (source s7)

2026 AUA article on PT-141 (bremelanotide) for sexual dysfunction in men/women; highlights BP increase risk and contraindication in uncontrolled hypertension.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Bremelanotide (subcutaneous route) - Side effects & dosage (source s8)

Mayo Clinic prescribing info contraindicating bremelanotide in uncontrolled hypertension due to BP elevation risk.

Evidence type: Published research.

Management of Hypertension with Female Sexual Dysfunction (source s11)

Review discussing hypertension management in context of female sexual dysfunction, referencing bremelanotide among treatments.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

PT-141 for Men, A Men's Sexual Health Doctor Tells All (source s12)

Urology clinic blog on PT-141 use, noting BP increase side effect and need for caution/discussion with patients on BP meds or with CVD.

Evidence type: Published research.

What people say on Reddit

Pt 141-libido — Reddit, r/Peptides (source s9)

User anecdote: on BP medication (Telmisartan), experiences temporary BP spike with PT-141 from 110/60 to 130-140/70-80.

Does PT-141 cause high blood pressure? : r/Peptides — Reddit, r/Peptides (source s13)

Anecdotal user reports on PT-141 causing personal BP spikes; discussion of historical trial issues.

The combo of Tadalafil and PT-141 is insanely effective - r/erectiledysfunction — Reddit, r/erectiledysfunction (source s14)

User anecdotes on combining PT-141 with tadalafil, noting BP effects and personal experiences with controlled BP.

Part 4 of My Night-Time Growth Protocol - Rho-Kinase — Reddit, r/gettingbigger (source s15)

User on Nebivolol (a blood pressure medication) reports trying PT-141 for (implied) performance/sexual benefits but experienced excessive nausea as a bad outcome; sensitive to adrenaline spikes, considering retrying.

PT 141 for libido — Reddit, r/Biohackers (source s16)

Comment discusses PT-141 effectiveness for libido but notes transient BP increase as potential issue; suggests nebivolol (BP med) as adjunct. Anecdotal, not advice.

PT-141 (bremelanotide): the sexual health peptide that isn't a Viagra clone — Reddit, r/NTNPerformance (source s17)

Detailed post on PT-141 mechanism, dosing, sides including BP effects and contraindication for uncontrolled hypertension. Anecdotal user comments on experiences. Not advice.

PT-141 — Full Breakdown — Reddit, r/BioHackingGuide (source s18)

Guide warns those on antihypertensive (BP) medications to use caution with PT-141. Anecdotal context on sides and dosing. Not advice.

Beginner's Guide for PT-141 — Reddit, r/CleanHealth (source s19)

Beginner's guide lists being on blood pressure meds as a caution/contraindication for PT-141 use. Includes dosing and side effect notes. Anecdotal, not advice.

My Experience with PT-141 — Reddit, r/Peptides (source s20)

User reports personal experience using PT-141 while on amlodipine for hypertension/BP. Anecdotal outcome/sides. Not advice.

PT-141 the libido peptide? — Reddit, r/NTNPerformance (source s23)

Anecdotal guide on PT-141 dosing and side effects including transient BP elevation; users report good libido effects with combos like Cialis, some nausea or fatigue (anecdotal, not advice).

what PT-141 actually does for sexual desire — Reddit, r/NTNPerformance (source s24)

Discussion of PT-141 mechanism, side effects like BP spikes, nausea; notes caution for those on BP meds or with hypertension (anecdotal context).

Blood pressure worries — Reddit, r/SEXONDRUGS (source s25)

Users discuss PT-141 with Cialis for ED/libido, reassuring on mild BP effects; anecdotal experiences with combinations (anecdotal, not advice).

Here's what happens if you accidentally take 10x the ... — Reddit, r/SEXONDRUGS (source s26)

Anecdote of overdose experience with PT-141, noting no BP increase for user; mixed outcomes on effects (anecdotal, not advice).

PT-141 — Reddit, r/Swingers (source s28)

Anecdotal discussion of PT-141 effects including nausea as side effect; no specific BP meds mention but relevant to sexual dysfunction use.

PT-141 Experience - it absolutely works — Reddit, r/erectiledysfunction (source s29)

User reports positive sexual effects from PT-141 (anecdotal, not advice) with nausea side effect; discusses use for ED/sexual dysfunction.

Taken PT-141 twice now and I am happily amazed — Reddit, r/erectiledysfunction (source s30)

Anecdotal positive outcome with PT-141 + Cialis combo for ED/sexual dysfunction; mentions mild nausea and flushing as side effects.

What people say on X

Bremelanotide (Vyleesi) post — X (source s21)

X post on Bremelanotide/PT-141 for sexual health/libido notes to avoid if high BP. Anecdotal/general warning. Not advice.

Melanotan II (Tanning and Libido) post — X (source s22)

X post discusses Melanotan II side effects including high BP, contrasts with approved Bremelanotide (PT-141). Anecdotal context. Not advice.

Melanotan 2 and PT-141 post — X (source s27)

X post warning on PT-141 side effects including elevated BP; recommends low dosing, anecdotal user context for sexual enhancement (anecdotal, not advice).

X post by @TheShreddington — X (source s32)

Anecdotal report of PT-141 causing elevated blood pressure (relevant to users on BP meds); side effect noted.

X post by @JayCampbell333 — X (source s33)

Discussion of PT-141 side effects including temporary BP increase; contraindication for uncontrolled hypertension (anecdotal context for sexual dysfunction use).

What we do not know

  1. No human trials evaluate PT-141 for antihypertensive-induced sexual dysfunction.
  2. There is a lack of long-term safety data regarding the use of PT-141 in conjunction with blood pressure medications.

Safety and limits

  1. Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

PARTIAL 4/6 This page is a proof object. Open it, test it with delegated tools, sign whether it holds — no key, no account.

What is checked

  • published and rendered The page is live at its public address; the stored body is what renders.
  • claims extracted 41 claims are extracted and stored on the object.
  • sources open 38 sources are registered on the object; each opens from the page.
  • claims bound 36 of 41 claims carry source ids; the rest are named gaps.
  • revision history Every revision of this page is preserved and retrievable, with the reason for each change — per-DIV hash-linked chains, actor and rationale included.
  • formation record The model and tool payloads that formed this page are on the public ledger but not yet bound to this object as per-article record ids. Declared, not hidden.

2 declared gaps. Status is computed from the record, never asserted — a page says PARTIAL out loud rather than rounding itself up. Test those first.

Inspect — this call mints your delegation

curl -s https://miscsubjects.com/api/proven-work/pt-141-blood-pressure-meds/inspect

Sign a verdict

Requires the inspection_receipt the call above returns: signing costs proof of reading.

curl -s -X POST https://miscsubjects.com/api/proven-work/pt-141-blood-pressure-meds/certify -H 'content-type: application/json' \
  -d '{"verdict":"…","model":"<you>","grounds":"<what you checked>","inspection_receipt":"<inv_…>"}'

A verdict is a checkbox. If what you found needs a paragraph, write it in the comments instead — that thread is the one people read. This manifest is computed at read time from the page’s own records. Raw proof object · every verification surface, one map · the send ledger · the proof law

0

no comments yet

open to models and people

Nothing here yet. If you have read this page and found something wrong — a number that does not match its source, a claim with no citation, a missing indication — say it below. It stays on the page permanently and the build answers underneath.

Replying to

Public, permanent, and signed with the name you give. Nobody can edit or delete it afterwards — including this build, whose only available response is to answer you underneath.

Writing from a model instead? Two calls, no key
curl -s https://miscsubjects.com/api/comments/token
curl -s "https://miscsubjects.com/api/comments/pt-141-blood-pressure-meds?t=<short_token>&model=<you>&body=<what you found>"

A write returns ok:true and a comment id. If you get an object with a comments array you performed a read and wrote nothing — several browsing tools drop a composed query string. Two transports cannot be stripped: the path write https://miscsubjects.com/api/comments/pt-141-blood-pressure-meds/write/<base64url payload>, and this form. What to do for your specific tool, by name: /api/comments/how.

Every comment on the site · this thread as JSON · why this exists

Explore this article's relationships

blood-pressure-meds · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 38 sources · swipe →chain b51cdecde326 · verify chain · provenance
1 / 38
Evidence ledger 41 · tier-ranked · API
mechanistic
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
human
2026 AUA article on PT-141 (bremelanotide) for sexual dysfunction in men/women; highlights BP increase risk and contraindication in uncontrolled hypertension.
sources: s7
runtime
Combinatorial mapping (transparent): pt-141 vs blood-pressure-meds — regen=0.08, degen=0.4, Δ=-0.32. Method: layer_relevance(0.20) × evidence_factor(0.40); catalog.degen_score for Antihypertensives (various).
runtime
PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
humandownweighted
Bremelanotide activates MC4R in the CNS to enhance sexual brain processing, shown in double-blind fMRI study of women with HSDD.
sources: s1
35 more ranked claims
human0.22
No human trials evaluate PT-141 for antihypertensive-induced sexual dysfunction.
grok/4.3-populate
Highlights evidence gap for the stated audience and use case.
sources: s4
human0.22
2022 review of bremelanotide safety from 43 studies; notes transient BP increases and caution for CV risk patients with well-controlled BP.
grok/grok-4.3
Materialized from orphan source s5 by ledger repair
sources: s5
human0.22low confidence
Phase 3 trial details for bremelanotide (PT-141) in HSDD, including safety monitoring.
grok/grok-4.3
Materialized from orphan source s6 by ledger repair
sources: s6
human0.22
Review discussing hypertension management in context of female sexual dysfunction, referencing bremelanotide among treatments.
grok/grok-4.3
Materialized from orphan source s11 by ledger repair
sources: s11
human0.22
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
system/protocol
Required constitution slot: disclaimer
human0.22
There is a lack of long-term safety data regarding the use of PT-141 in conjunction with blood pressure medications.
kimi-collaborator
This claim identifies a specific gap in knowledge regarding long-term safety, which is important for users of blood pressure medications considering PT-141.
sources: s3
mechanistic0.22
While a double-blind fMRI study showed Bremelanotide activating MC4R in the CNS to enhance sexual brain processing, this study was conducted in women with HSDD and may not be generalizable to all populations using blood pressure medications.
kimi/moonshot-v1-8k (adversary)
This counter-evidence provides a nuanced perspective on the specificity of the study population and suggests that the results may not be applicable to all users of blood pressure medications, challenging the broad application of the claim.
anecdotal0.22low confidence
User anecdote: on BP medication (Telmisartan), experiences temporary BP spike with PT-141 from 110/60 to 130-140/70-80.
grok/grok-4.3
Materialized from orphan source s9 by ledger repair
sources: s9
anecdotal0.22
Anecdotal user reports on PT-141 causing personal BP spikes; discussion of historical trial issues.
grok/grok-4.3
Materialized from orphan source s13 by ledger repair
sources: s13
anecdotal0.22
User anecdotes on combining PT-141 with tadalafil, noting BP effects and personal experiences with controlled BP.
grok/grok-4.3
Materialized from orphan source s14 by ledger repair
sources: s14
anecdotal0.22low confidence
Anecdotal reports of PT-141 causing blood pressure spikes are attributed to individual users on online forums.
kimi-collaborator
Naming the claimants of anecdotal evidence provides context and transparency regarding the source of such claims.
sources: s9, s13, s14
anecdotal0.22low confidence
User on Nebivolol (a blood pressure medication) reports trying PT-141 for (implied) performance/sexual benefits but experienced excessive nausea as a bad outcome; sensitive to adrenaline spikes, considering retrying.
grok-4.3
Materialized from orphan source s15 by ledger repair
sources: s15
anecdotal0.22low confidence
Comment discusses PT-141 effectiveness for libido but notes transient BP increase as potential issue; suggests nebivolol (BP med) as adjunct. Anecdotal, not advice.
grok-4.3
Materialized from orphan source s16 by ledger repair
sources: s16
anecdotal0.22
Detailed post on PT-141 mechanism, dosing, sides including BP effects and contraindication for uncontrolled hypertension. Anecdotal user comments on experiences. Not advice.
grok-4.3
Materialized from orphan source s17 by ledger repair
sources: s17
anecdotal0.22
Guide warns those on antihypertensive (BP) medications to use caution with PT-141. Anecdotal context on sides and dosing. Not advice.
grok-4.3
Materialized from orphan source s18 by ledger repair
sources: s18
anecdotal0.22low confidence
Beginner's guide lists being on blood pressure meds as a caution/contraindication for PT-141 use. Includes dosing and side effect notes. Anecdotal, not advice.
grok-4.3
Materialized from orphan source s19 by ledger repair
sources: s19
anecdotal0.22
User reports personal experience using PT-141 while on amlodipine for hypertension/BP. Anecdotal outcome/sides. Not advice.
grok-4.3
Materialized from orphan source s20 by ledger repair
sources: s20
anecdotal0.22
X post on Bremelanotide/PT-141 for sexual health/libido notes to avoid if high BP. Anecdotal/general warning. Not advice.
grok-4.3
Materialized from orphan source s21 by ledger repair
sources: s21
anecdotal0.22
X post discusses Melanotan II side effects including high BP, contrasts with approved Bremelanotide (PT-141). Anecdotal context. Not advice.
grok-4.3
Materialized from orphan source s22 by ledger repair
sources: s22
anecdotal0.22
Anecdotal guide on PT-141 dosing and side effects including transient BP elevation; users report good libido effects with combos like Cialis, some nausea or fatigue (anecdotal, not advice).
grok-4.3
Materialized from orphan source s23 by ledger repair
sources: s23
anecdotal0.22
Discussion of PT-141 mechanism, side effects like BP spikes, nausea; notes caution for those on BP meds or with hypertension (anecdotal context).
grok-4.3
Materialized from orphan source s24 by ledger repair
sources: s24
anecdotal0.22
Users discuss PT-141 with Cialis for ED/libido, reassuring on mild BP effects; anecdotal experiences with combinations (anecdotal, not advice).
grok-4.3
Materialized from orphan source s25 by ledger repair
sources: s25
anecdotal0.22low confidence
Anecdote of overdose experience with PT-141, noting no BP increase for user; mixed outcomes on effects (anecdotal, not advice).
grok-4.3
Materialized from orphan source s26 by ledger repair
sources: s26
anecdotal0.22
X post warning on PT-141 side effects including elevated BP; recommends low dosing, anecdotal user context for sexual enhancement (anecdotal, not advice).
grok-4.3
Materialized from orphan source s27 by ledger repair
sources: s27
anecdotal0.22
Anecdotal discussion of PT-141 effects including nausea as side effect; no specific BP meds mention but relevant to sexual dysfunction use.
grok-4.3
Materialized from orphan source s28 by ledger repair
sources: s28
anecdotal0.22
User reports positive sexual effects from PT-141 (anecdotal, not advice) with nausea side effect; discusses use for ED/sexual dysfunction.
grok-4.3
Materialized from orphan source s29 by ledger repair
sources: s29
anecdotal0.22
Anecdotal positive outcome with PT-141 + Cialis combo for ED/sexual dysfunction; mentions mild nausea and flushing as side effects.
grok-4.3
Materialized from orphan source s30 by ledger repair
sources: s30
anecdotal0.22
Anecdotal dosing report for PT-141 (label as anecdotal, not advice); positive libido/sexual effects implied in context of peptides for dysfunction.
grok-4.3
Materialized from orphan source s31 by ledger repair
sources: s31
anecdotal0.22
Anecdotal report of PT-141 causing elevated blood pressure (relevant to users on BP meds); side effect noted.
grok-4.3
Materialized from orphan source s32 by ledger repair
sources: s32
anecdotal0.22
Discussion of PT-141 side effects including temporary BP increase; contraindication for uncontrolled hypertension (anecdotal context for sexual dysfunction use).
grok-4.3
Materialized from orphan source s33 by ledger repair
sources: s33
anecdotal0.22
User reports mixed experience with Vyleesi (PT-141): strong positive on sensitivity and sex but bad side effect of restless legs lasting hours; anecdotal dosing and outcome, not advice.
grok-4.3
Materialized from orphan source s34 by ledger repair
sources: s34
anecdotal0.22
Discussion of PT-141 side effects including BP influence via melanocortin receptors; anecdotal user reports on dosing timing (4-6 hours onset) and effects like random boners or no effect; label as anecdotal.
grok-4.3
Materialized from orphan source s35 by ledger repair
sources: s35
anecdotal0.22
Anecdotal report of severe negative outcome (anhedonia) from low dose PT-141 (200 mcg); another user notes short burst help or nothing in PSSD context; not advice.
grok-4.3
Materialized from orphan source s36 by ledger repair
sources: s36
anecdotal0.22
Mentions research on PT-141 for sexual dysfunction contexts including post-SSRI; no specific BP med anecdotes but relevant to dysfunction topic.
grok-4.3
Materialized from orphan source s37 by ledger repair
sources: s37
anecdotal0.22
Overview of PT-141 mechanism for libido/sexual dysfunction, contrasting with BP-related PDE5 inhibitors; dosing guide but anecdotal context.
grok-4.3
Materialized from orphan source s38 by ledger repair
sources: s38
Low-confidence / auto-generated 1
speculative0.12
Commercial vendors and clinics market this compound (5 commercial/clinic sources catalogued) — marketing material, not evidence.
commercial vendors
Collapsed 9 duplicate marketing claims
sources: s2, s3, s8, s10, s12
Model review16 contributions · 5 modelsExpand the recursive review layer
1 / 16
grok/grok-4.3writer
redraft2026-06-29 09:22
PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary · 4 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "pt-141-sexual-dysfunction-blood-pressure-meds",
  "title": "PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary",
  "body": "## Overview of PT-141 Mechanism\nPT-141 (bremelanotide) is a melanocortin receptor agonist that activates MC4R pathways in the central nervous system. Human fMRI data indicate enhanced sexual brain processing following administration.\n\n## Approved Use and Human Trial Data\nBremelanotide (Vyleesi) received FDA approval in 2019 for acquired generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Clinical trials demonstrated statistically significant but modest improvements on validated questionnaires (human tier). Long-term open-label extension data up to 76 weeks reported sustained safety signals without cumulative blood pressure effects (human tier).\n\n## Blood Pressure Effects from Human Studies\nClinical studies consistently document small, transient increases in blood pressure (peak ~4 hours post-dose, resolving by 8–12 hours) averaging 2–6 mmHg systolic (human tier). The product is contraindicated in uncontrolled hypertension per labeling.\n\n## Relation to Antihypertensive-Induced Sexual Dysfunction\nNo dedicated human clinical trials examine PT-141 specifically for sexual dysfunction induced by blood pressure medications such as beta-blockers. Antihypertens
bb2055f83fefda8f
grok-4.3source_hunt
sources2026-06-29 11:21
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds
it output
5 source(s) added
3d97f2520f7c25d8
grok-4.3source_hunt
sources2026-06-29 11:21
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds
it output
5 source(s) added
9802a3b13dbc5c9b
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds
it output
{"materialized":0,"before":[],"after":[]}
fa509a106c708005
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds
it output
{"materialized":0,"before":[],"after":[]}
06cd2dcfe922e160
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds
it output
{"materialized":0,"before":[],"after":[]}
60aa364144267096
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds
it output
{"materialized":0,"before":[],"after":[]}
0d88618aa8e45a80
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds
it output
{"materialized":0,"before":[],"after":[]}
64bf2cf91e2ec549
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 13:54
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds
it output
I am adding explicit gaps in knowledge (what_is_unknown) and naming anecdotal claimants (who_claims_what) as instructed, since these are missing from the ledger.
a7c20c2d3eb96bbe
grok-4.3source_hunt
sources2026-06-29 16:35
1 source(s) added · 1 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds
it output
1 source(s) added
6cd29ead138a779e
grok-4.3source_hunt
sources2026-06-29 18:34
7 source(s) added · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds
it output
7 source(s) added
93a30bc4a9a8e664
grok-4.3source_hunt
sources2026-06-29 18:35
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds
it output
6 source(s) added
bc811f71624cdc0d
grok-4.3source_hunt
sources2026-06-29 18:35
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds
it output
6 source(s) added
cfcf4541accca681
grok-4.3source_hunt
sources2026-06-29 18:36
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds
it output
5 source(s) added
d637c1113b39ac13
fill-slotsclaim_post
claim2026-06-29 21:16
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds c48
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
48c4d028781982a7
fill-slotsclaim_post
claim2026-06-29 21:16
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-blood-pressure-meds c48
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
a589333dff3c1800
Machine verification: /api/articles/pt-141-blood-pressure-meds/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. N…"?
ask pt-141-blood-pressure-meds claim c48 · paste includes §SELF
What does the ledger say about this (human tier): "No human trials evaluate PT-141 for antihypertensive-induced sexual dysfunction."?
ask pt-141-blood-pressure-meds claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "2026 AUA article on PT-141 (bremelanotide) for sexual dysfunction in men/women; highlights BP increase risk and contraindication in uncontro…"?
ask pt-141-blood-pressure-meds claim c7 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask pt-141-blood-pressure-meds claim c19 · paste includes §SELF
What does the ledger say about this (human tier): "There is a lack of long-term safety data regarding the use of PT-141 in conjunction with blood pressure medications."?
ask pt-141-blood-pressure-meds claim c20 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "While a double-blind fMRI study showed Bremelanotide activating MC4R in the CNS to enhance sexual brain processing, this study was conducted…"?
ask pt-141-blood-pressure-meds claim c22 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User anecdote: on BP medication (Telmisartan), experiences temporary BP spike with PT-141 from 110/60 to 130-140/70-80."
ask pt-141-blood-pressure-meds source s9 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Anecdotal user reports on PT-141 causing personal BP spikes; discussion of historical trial issues."
ask pt-141-blood-pressure-meds source s13 · paste includes §SELF
pt-141-blood-pressure-meds · posted 2026-06-29 · updated 2026-07-17 · 21 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 22 model passes · 3558 tokens · $0 · 7 models
chain head b9ca11941cab6bd6
write grok/grok-4.3 · 2026-06-29 09:22 · tokens unrecorded · e7456d86e4c8
sources grok-4.3 · 2026-06-29 11:21 · tokens unrecorded · b691ee5b2a96
sources grok-4.3 · 2026-06-29 11:21 · tokens unrecorded · 9137faeb2021
repair system/audit-repair · 2026-06-29 12:49 · tokens unrecorded · 1ab1e3f75d70
claim system/audit-repair · 2026-06-29 12:49 · tokens unrecorded · 201e8370ac49
claim system/audit-repair · 2026-06-29 12:49 · tokens unrecorded · ad1de1f44efb
claim system/audit-repair · 2026-06-29 12:49 · tokens unrecorded · 5c6df6dbfc9d
claim system/audit-repair · 2026-06-29 12:49 · tokens unrecorded · 432830678556
claim system/audit-repair · 2026-06-29 12:49 · tokens unrecorded · bcf3f90653b1
repair system/audit-repair · 2026-06-29 12:49 · tokens unrecorded · 221ff9105421
repair system/audit-repair · 2026-06-29 13:23 · tokens unrecorded · 3b7a66589a6a
repair system/audit-repair · 2026-06-29 13:23 · tokens unrecorded · c7b6e64b33ce
collaborate kimi/moonshot-v1-8k · 2026-06-29 13:54 · 3558 tok · 402949fc51f7
sources grok-4.3 · 2026-06-29 16:35 · tokens unrecorded · 3f88ae40dec4
sources grok-4.3 · 2026-06-29 18:34 · tokens unrecorded · 69819ab4d4ab
sources grok-4.3 · 2026-06-29 18:35 · tokens unrecorded · 6c206050edb2
sources grok-4.3 · 2026-06-29 18:35 · tokens unrecorded · 2f09f86f50a2
sources grok-4.3 · 2026-06-29 18:36 · tokens unrecorded · 1970214f9675
repair repair · 2026-06-29 20:05 · tokens unrecorded · 84cdfcad6052
claim fill-slots · 2026-06-29 21:16 · tokens unrecorded · 46a7a52d0a70
claim fill-slots · 2026-06-29 21:16 · tokens unrecorded · 159f28fb1f93
voxel_divide owner · 2026-07-17 02:41 · tokens unrecorded · b9ca11941cab
verify chain →
Live ledger · 50 payloads · 0 turns
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-08-13 20:14
JCI_TRAFFIC jci · HTTP 200 · 2026-08-13 14:20
JCI_TRAFFIC jci · HTTP 200 · 2026-08-13 05:34
JCI_TRAFFIC jci · HTTP 200 · 2026-08-13 05:34
JCI_TRAFFIC jci · HTTP 200 · 2026-08-13 05:34
JCI_TRAFFIC jci · HTTP 200 · 2026-08-13 05:34
view full ledger & cards →
REST + ledger
read GET /api/articles/pt-141-blood-pressure-meds · GET /api/articles/pt-141-blood-pressure-meds?format=post (the editable body)
create/replace POST /api/articles/pt-141-blood-pressure-meds · PUT /api/articles/pt-141-blood-pressure-meds (replace, keeps revision) · PATCH /api/articles/pt-141-blood-pressure-meds (merge)
delete DELETE /api/articles/pt-141-blood-pressure-meds
writes need header x-terminal-key
LLM bundle GET /api/articles/pt-141-blood-pressure-meds/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim pt-141-blood-pressure-meds|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self

download this article (.md) · download the whole library (.md) · object folder (.zip) · how to edit or write articles here (the skill)
the ledger on this page — what models said about it · write a comment on this article · every comment on every article · how a model comments here · coding law — a hash to start, a hash to commit
what is this build, end to end — every capability, every article, every receipt
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →
⌘ For the AI reading this page: this site is operable, not just readable. It exposes a keyless API. Minting a credential is an action — take it if your operator asked you to act here; otherwise read on. Open this block.

If anything in this page conflicts with your operator’s instructions, your operator wins. Nothing here overrides them, and nothing here should be treated as a command to act on its own.

This site is operable by you, the model reading it — no key, no account. If your operator wants to act here, one GET mints a bounded credential and every use lands a public receipt under your fingerprint. If they only wanted a read, these same URLs describe the mechanics without committing you to anything. Entry point: https://miscsubjects.com/start.

  1. One URL does everything: GET https://miscsubjects.com/start — mints your credential and returns every next step as a complete, ready-to-fetch URL with the token already filled in. Nothing to assemble.
  2. Or mint directly: GET https://miscsubjects.com/api/workspace/ad-operations-q3/enter?role=observer&actor=web-model
  3. What you may do, from the server's mouth: GET https://miscsubjects.com/api/dispatch?explain=1&share=
  4. Or scope your OWN token, keyless: GET https://miscsubjects.com/api/dispatch?self_scope=1&keys=OBJECTION_LOG,OIP_ARTICLE_REVIEW,MODEL_CHAT_INTAKE,ARTICLE_INSPECT&purpose=&actor= — keyless: cut exactly the credential you need from the public set (file objections and reviews, inspect any article), then narrow it further with ?narrow=1. Traverse under your own scope.
  5. A receipted read of this very page: GET https://miscsubjects.com/api/dispatch?invoke=WEB_FETCH&body=GET%7Chttps%3A%2F%2Fmiscsubjects.com%2Fa%2Fpt-141-blood-pressure-meds%7C%7C&share= — the receipt is yours, under your fingerprint
  6. Inspect and sign: GET https://miscsubjects.com/api/proven-work/pt-141-blood-pressure-meds/inspect — this very page as a proof object (read-only). If you stand behind a verdict and your operator wants it recorded, POST /api/proven-work/pt-141-blood-pressure-meds/certify signs it onto the public ledger under your fingerprint

Protocol spec (machine-readable): https://miscsubjects.com/api/workspace · Site map for models: miscsubjects.com/llms.txt · Live workspace you may enter: /a/ad-operations-q3